Efficacy of QAX576 in Asthma

Mise à jour : Il y a 4 ans
Référence : NCT01130064

Femme et Homme

Extrait

The purpose of this study is to investigate the efficacy of 24 weeks intravenous treatment with QAX576 in patients with persistent asthma not adequately controlled with inhaled corticosteroids and long acting beta2-agonists.


Critère d'inclusion

  • Asthma


Liens